TY - JOUR
T1 - The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation
AU - Shimokawa, Hiroaki
AU - Yasutake, Hiroshi
AU - Fujii, Koji
AU - Owada, M. Koji
AU - Nakaike, Ryuichi
AU - Fukumoto, Yoshihiro
AU - Takayanagi, Tsuneo
AU - Nagao, Tetsuhiko
AU - Egashira, Kensuke
AU - Fujishima, Masatoshi
AU - Takeshita, Akira
PY - 1996
Y1 - 1996
N2 - Endothelium-dependent relaxations are achieved by a combination of endothelium-derived prostacyclin (PGI2), nitric oxide (NO), and endothelium- derived hyperpolarizing factor (EDHF). However, it remains to be fully clarified whether the relative contribution of these three mechanisms to endothelium-dependent relaxations varies as a function of the vessel size. This study was designed to clarify this point. Acetylcholine (ACh)-induced endothelium-dependent relaxations were examined in isolated blood vessels taken from the aorta and the proximal and distal mesenteric arteries of the rat. The contributions of PGI2, NO, and EDHF were evaluated by the inhibitory effects of indomethacin, N(ω)-nitro-L-arginine methyl ester (L- NAME) in the presence of indomethacin, and KCl in the presence of indomethacin and L-NAME, respectively. The membrane potentials were recorded with microelectrodes. The expression of endothelial NO synthase (eNOS) was examined by both immunostaining and immunoblotting. The contribution of PGI2 was negligible in three different sized blood vessels. The contribution of NO was most prominent in the aorta, whereas that of EDHF was most prominent in the distal mesenteric arteries. The resting membrane potential was significantly deeper and the ACh-induced hyperpolarization was greater in the distal mesenteric arteries than those in the aorta. The expression of eNOS was the highest in the aorta and the lowest in the distal mesenteric arteries. These results indicate that the importance of EDHF increases as the vessel size decreases in endothelium-dependent relaxations in the rat mesenteric circulation.
AB - Endothelium-dependent relaxations are achieved by a combination of endothelium-derived prostacyclin (PGI2), nitric oxide (NO), and endothelium- derived hyperpolarizing factor (EDHF). However, it remains to be fully clarified whether the relative contribution of these three mechanisms to endothelium-dependent relaxations varies as a function of the vessel size. This study was designed to clarify this point. Acetylcholine (ACh)-induced endothelium-dependent relaxations were examined in isolated blood vessels taken from the aorta and the proximal and distal mesenteric arteries of the rat. The contributions of PGI2, NO, and EDHF were evaluated by the inhibitory effects of indomethacin, N(ω)-nitro-L-arginine methyl ester (L- NAME) in the presence of indomethacin, and KCl in the presence of indomethacin and L-NAME, respectively. The membrane potentials were recorded with microelectrodes. The expression of endothelial NO synthase (eNOS) was examined by both immunostaining and immunoblotting. The contribution of PGI2 was negligible in three different sized blood vessels. The contribution of NO was most prominent in the aorta, whereas that of EDHF was most prominent in the distal mesenteric arteries. The resting membrane potential was significantly deeper and the ACh-induced hyperpolarization was greater in the distal mesenteric arteries than those in the aorta. The expression of eNOS was the highest in the aorta and the lowest in the distal mesenteric arteries. These results indicate that the importance of EDHF increases as the vessel size decreases in endothelium-dependent relaxations in the rat mesenteric circulation.
UR - http://www.scopus.com/inward/record.url?scp=10544239533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10544239533&partnerID=8YFLogxK
U2 - 10.1097/00005344-199611000-00014
DO - 10.1097/00005344-199611000-00014
M3 - Article
C2 - 8945685
AN - SCOPUS:10544239533
SN - 0160-2446
VL - 28
SP - 703
EP - 711
JO - Journal of Cardiovascular Pharmacology
JF - Journal of Cardiovascular Pharmacology
IS - 5
ER -